Connect Biopharma Holdings (CNTB) Capital Expenditures (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Capital Expenditures of -$2000.0 for Q1 2026, down 102.47% year-on-year from $81000.0 in Q1 2025, and down 101.07% on a QoQ basis from $187000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Capital Expenditures (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Capital Expenditures for 3 consecutive years, with -$2000.0 the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures fell 102.47% year-over-year to -$2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $522000.0 (down 37.11% YoY) and the FY2025 annual result came in at $605000.0, down 19.33% from the prior year.
- Capital Expenditures retreated to -$2000.0 in Q1 2026 per CNTB's latest filing, from $187000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for CNTB reached as high as $313000.0 in Q4 2024 and fell as low as -$2000.0 in Q1 2026.
- A 3-year average of $150333.3 and a median of $147000.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2025 — Capital Expenditures surged 8000.0% — and 2026, when it plunged 102.47%.
- Year by year, Capital Expenditures stood at $313000.0 in 2024, then slumped by 40.26% to $187000.0 in 2025, then tumbled by 101.07% to -$2000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$2000.0, $187000.0, and $34000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 187,000.00 |
| Dec 31, 2025 | 187,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 303,000.00 |
| Jun 30, 2025 | 303,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 313,000.00 |
| Dec 31, 2024 | 313,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Sep 30, 2024 | 147,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 289,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |